| Literature DB >> 34307664 |
Stefan G Pierzynowski1,2,3, Anna Socha-Banasiak4, Monika Sobol5, Grzegorz Skiba6, Stanisława Raj6, Olena Dovban7, Galyna Ushakova7, Jarosław Woliński5,8, Nadiia Mosiichuk9, Paulina Szczurek-Janicka10, Marek Pieszka10, Marian Kamyczek11, Ewa Święch6, Halyna Shmigel9, Marcin Sonta12, Elżbieta Czkwianianc4, Kateryna Pierzynowska1,2,8.
Abstract
Pancreatic enzyme replacement therapy (PERT) and fat predigestion are key in ensuring the optimal growth of patients with cystic fibrosis. Our study attempted to highlight differences between fat predigestion and conventional PERT on body composition of young pigs with exocrine pancreatic insufficiency (EPI). EPI and healthy pigs were fed with high-fat diet for six weeks. During the last two weeks of the study, all pigs received additional nocturnal alimentation with Peptamen AF (PAF) and were divided into three groups: H-healthy pigs receiving PAF; P-EPI pigs receiving PAF+PERT; and L-EPI pigs receiving PAF predigested with an immobilized microbial lipase. Additional nocturnal alimentation increased the body weight gain of EPI pigs with better efficacy in P pigs. Humerus length and area in pigs in groups L and P were lower than that observed in pigs in group H (p value 0.005-0.088). However, bone mineral density and strength were significantly higher in P and L as compared to that of H pigs (p value 0.0026-0.0739). The gut structure was improved in P pigs. The levels of neurospecific proteins measured in the brain were mainly affected in P and less in L pigs as compared to H pigs. The beneficial effects of the nocturnal feeding with the semielemental diet in the prevention of EPI pigs' growth/development retardation are differently modified by PERT or fat predigestion in terms of growth, bone properties, neurospecific protein distribution, and gut structure.Entities:
Year: 2021 PMID: 34307664 PMCID: PMC8282365 DOI: 10.1155/2021/6647734
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Ingredients, chemical composition, and nutritive value of the high-fat diet with 20% fat content (HF20).
| Indices | HF20 |
|---|---|
| Ingredients (g/kg) | |
| Barley | 261.00 |
| Wheat | 274.80 |
| Soybean meal | 200.00 |
| Fish meal (65% crude protein) | 20.00 |
| Rapeseed oil | 200.00 |
| Premix 0.5% grower1 | 5.00 |
| Monocalcium phosphate | 15.00 |
| Fodder chalk | 10.00 |
| Fodder salt | 2.00 |
| Zinc oxide | 0.17 |
| Lysine | 5.00 |
| Methionine | 2.00 |
| Threonine | 2.00 |
| Tryptophan | 2.00 |
| Acidifier | 1.00 |
|
| |
| Chemical composition (g/kg) | |
| Dry matter | 905 |
| Ash | 24.3 |
| Organic matter | 881 |
| Crude protein | 166 |
| Ether extract | 216 |
| Crude fibre | 33.5 |
| Starch | 311 |
|
| |
| Nutritive value (determined) (g/kg) | |
| Lysine | 13.20 |
| Methionine | 4.65 |
| Threonine | 7.80 |
| Tryptophan | 3.90 |
| P | 6.97 |
| Ca | 9.56 |
| Na | 1.14 |
|
| |
| Metabolisable energy (MJ/kg) | 16.8 (4012.7 kcal) |
| Lysine/metabolisable energy (g/MJ) | 0.79 |
Body weight (BW) and total weight gain (TWG) of experimental animals.
| Item | Group |
| ||||
|---|---|---|---|---|---|---|
| H | P | L | P vs. H | L vs. H | L vs. P | |
| BW | ||||||
| 64 days of age | 9.85 ± 0.34 | 8.57 ± 0.30 | 8.71 ± 0.26 | 0.0222 | 0.0465 | 0.9435 |
| 74 days of age | 13.73 ± 0.42 | 11.07 ± 0.38 | 10.63 ± 0.33 | 0.0002 | 0.0010 | 0.6865 |
|
| ||||||
| TWG | ||||||
| 35-64 days of age | 2.98 ± 0.19 | 0.90 ± 0.17 | 0.79 ± 0.15 | 0.0001 | 0.0001 | 0.8964 |
| 64-74 days of age | 3.88 ± 0.16 | 2.50 ± 0.14 | 1.92 ± 0.12 | 0.0001 | 0.0001 | 0.0124 |
| 35-74 days of age | 6.86 ± 0.31 | 3.40 ± 0.28 | 2.71 ± 0.25 | 0.0001 | 0.0001 | 0.1992 |
H: healthy pigs+PAF; P: EPI pigs+PAF enriched with enteric-coated pig pancreatic enzymes; L: EPI pigs+PAF predigested with microbial lipase. Data are presented as the mean ± SD.
Whole-body composition and bone properties of experimental animals at the end of the study.
| Item | Group |
| ||||
|---|---|---|---|---|---|---|
| H | P | L | P vs. H | L vs. H | L vs. P | |
| Whole-body composition | ||||||
| Lean mass (kg) | 11.94 ± 0.36 | 10.09 ± 0.32 | 9.71 ± 0.28 | 0.0014 | 0.0020 | 0.6890 |
| Fat mass (kg) | 1.84 ± 0.10 | 0.93 ± 0.09 | 0.85 ± 0.08 | 0.0001 | 0.0001 | 0.8476 |
| Total fat (%) | 12.63 ± 0.65 | 8.10 ± 0.58 | 7.23 ± 0.51 | 0.0001 | 0.0001 | 0.5462 |
| Bone area (cm2) | 705.4 ± 13.02 | 678.1 ± 11.63 | 658.3 ± 10.2 | 0.3060 | 0.0327 | 0.4540 |
| BMC (g) | 260.8 ± 7.81 | 256.6 ± 6.98 | 249.9 ± 6.12 | 0.9228 | 0.5898 | 0.7809 |
|
| ||||||
| Morphometry, densitometry, and biomechanical properties of humeri | ||||||
| Mass (g) | 58.34 ± 1.97 | 53.15 ± 1.76 | 50.52 ± 1.54 | 0.1554 | 0.0168 | 0.5445 |
| Length (mm) | 100.99 ± 1.07 | 96.59 ± 0.95 | 96.30 ± 0.84 | 0.0123 | 0.0070 | 0.9739 |
| Area (cm2) | 25.84 ± 0.56 | 24.13 ± 0.51 | 23.24 ± 0.44 | 0.0877 | 0.0047 | 0.4314 |
| BMC (g) | 10.14 ± 0.40 | 10.30 ± 0.36 | 9.73 ± 0.32 | 0.9590 | 0.7543 | 0.5107 |
| BMD (g/cm2) | 0.391 ± 0.01 | 0.422 ± 0.01 | 0.416 ± 0.01 | 0.0242 | 0.0739 | 0.8673 |
| Maximum strength (kg) | 80.83 ± 3.51 | 97.93 ± 3.14 | 96.09 ± 2.75 | 0.0026 | 0.0079 | 0.9093 |
H: healthy pigs+PAF; P: EPI pigs+PAF enriched with enteric-coated pig pancreatic enzymes; L: EPI pigs+PAF predigested with microbial lipase. Data are presented as the mean ± SD.
Figure 1Histomorphometry (mucosa thickness, villi length, crypt depth, and muscularis thickness) of the middle part of the jejunum at the end of the study on healthy pigs fed a HFD and EPI pigs fed a HFD either with PERT or with microbial lipase, with all pigs receiving additional nocturnal feeding with Peptamen AF (PAF). H: healthy pigs+PAF; P: EPI pigs+PAF enriched with enteric-coated pig pancreatic enzymes; L: EPI pigs+PAF predigested with microbial lipase. Data are presented as the mean ± SD. Small letters given with result bars describe significant differences when p < 0.05.
Neurospecific protein distribution (μg/100 mg of tissue) in cerebellum and hippocampus.
| Protein, brain area | Group |
| ||||
|---|---|---|---|---|---|---|
| H | P | L | P vs. H | L vs. H | L vs. P | |
| sNCAM, cerebellum | 0.52 ± 0.13 | 0.31 ± 0.11 | 0.46 ± 0.17 | 0.049 | 0.684 | 0.188 |
| sNCAM, hippocampus | 0.40 ± 0.07 | 0.59 ± 0.15 | 0.61 ± 0.08 | 0.014 | 0.008 | 0.962 |
| sGFAP, cerebellum | 20.48 ± 1.84 | 18.57 ± 0.68 | 19.19 ± 0.96 | 0.030 | 0.169 | 0.615 |
| sGFAP, hippocampus | 16.46 ± 0.98 | 13.33 ± 0.84 | 13.83 ± 2.21 | 0.004 | 0.015 | 0.809 |
| fGFAP, cerebellum | 134.70 ± 11.01 | 155.9 ± 10.75 | 136.00 ± 3.46 | 0.012 | 0.969 | 0.018 |
| fGFAP, hippocampus | 142.90 ± 14.57 | 84.57 ± 11.18 | 156.10 ± 14.27 | <0.001 | 0.208 | <0.001 |
sNCAM: soluble neural cell adhesion molecule; sGFAP: soluble glial fibrillary acidic protein; fGFAP: filamentous glial fibrillary acidic protein; H: healthy pigs+PAF; P: EPI pigs+PAF enriched with enteric-coated pig pancreatic enzymes; L: EPI pigs+PAF predigested with microbial lipase. Data are presented as the mean ± SD.